RWJBarnabas Health and Rutgers Cancer Institute of New Jersey opened the $1 billion Jack & Sheryl Morris Cancer Center in May of 2025 in New Brunswick. Designed by HOK, the 520,000-sf building collocates world-class research environments with welcoming settings for clinical care to optimize patient outcomes.
Yale New Haven Hospital is constructing the Adams Neurosciences Center on its Saint Raphael Campus in New Haven. Integrating research, clinical care, and medical education, the $838 million facility was designed by Shepley Bulfinch to set a new benchmark for neurological care in Connecticut. The two-tower, 505,000-sf complex will feature translational research laboratories for the creation of new therapies for Parkinson’s, Alzheimer’s, epilepsy, multiple sclerosis, and strokes.
Biogen is planning to centralize its operations with a 580,000-sf global headquarters in the Kendall Common development in Cambridge, Mass. Representing a 15-year lease agreement, the facility’s strategic location will strengthen existing partnerships with MIT in research, education, and commercialization, and build on Biogen’s legacy as an integral part of the Kendall Square ecosystem.
The Medical College of Wisconsin is constructing the $153 million Center for Cancer Discovery on the Milwaukee Regional Medical Center campus. Centralizing the university’s cancer research programs under one roof, this dynamic hub will catalyze discoveries in cancer biology, expand clinical trials, and create groundbreaking treatments for patients.
Cleveland Clinic is constructing the $1.1 billion Neurological Institute in Cleveland, Ohio. The 1.2 million-sf translational research facility will consolidate 15 separate centers to catalyze interdisciplinary synergies and improve patient outcomes. Spanning fourteen stories, the state-of-the-art hospital will offer a comprehensive array of services such as neuro-simulation training, infusion therapy, neurodiagnostics, brain mapping suites, imaging, and digitized patient evaluations.
An evolution of the equipment and technology researchers need is transforming ordinary labs into facilities that deserve to be called next-generation or future-ready. Significant changes in space utilization and lab planning and design are driven by increased automation and robotics, the incorporation of manufacturing, enhanced information technology with an emphasis on data collection, ever-evolving technologies, developer core/shell fit-outs, hybrid work patterns, and different approaches to project delivery and construction.
Ohio University began construction in January of 2025 on the $75 million Heritage Translational Research Center (HTRC) in Athens. Designed by Perkins&Will and DesignGroup, the 80,000-sf facility will consolidate laboratories and operations currently dispersed across campus, creating a collaborative ecosystem for clinical innovation. The four-story structure will provide bench space for translational biomedical research, as well as labs and support spaces for population health and clinical research.
The University of Maryland, Baltimore opened a 250,000-sf innovation center in January of 2024 to drive biomedical advances and accelerate the discovery of new health solutions. Developed and operated by Wexford Science + Technology, 4MLK serves as the gateway to the UM BioPark and will offer leasable space for life science and technology companies.
Massachusetts General Hospital is constructing the Herb Chambers Tower in Boston to meet a growing demand for world-class cancer services. Collocating inpatient and outpatient environments, the nearly 1 million-sf building will enable patients to receive the continuum of their care under one roof. Clinical teams will work in dynamic collaboration to optimize medical outcomes and further life-saving research utilizing the latest tools and instrumentation.
The University of California is planning to construct the UCSF Life Sciences Building as part of a major redevelopment of the former Dogpatch Power Station in San Francisco. The transformative facility will bring research, innovation, primary and specialty care clinics, and world-class cancer treatment to a new waterfront destination. Standing eight stories above ground, the structure will include two basement levels for a state-of-the-art proton therapy center that will begin operations in 2029.
Siteman Cancer Center celebrated the opening of a new world-class destination for cancer care in St. Louis in September of 2024. Created in partnership between Barnes-Jewish Hospital and Washington University School of Medicine, the 657,250-sf facility enables an innovative model of care that allows a patient to interact with a multidisciplinary team on a single visit. This approach prioritizes patients’ comfort and convenience, while reducing the need for additional appointments.
